RCS - Intnl. Biotechnology - Latest Factsheet and Blog

International Biotechnology Trust

08/10/2024 14:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241008:nRSH3850Ha&default-theme=true

RNS Number : 3850H  Intl. Biotechnology Trust PLC  08 October 2024

INTERNATIONAL BIOTECHNOLOGY TRUST PLC ("IBT")

 

Latest Factsheet and Blog

 

 

IBT's factsheet for the month ended 31 August 2024 is now available directly
via its web page. Please click here
(https://www.schroders.com/en-gb/uk/individual/funds-and-strategies/investment-trusts/international-biotechnology-trust/)
, then 'latest factsheet'.

 

In the latest blog post, Fund Managers Ailsa Craig and Marek Poszepczynski
look back on another year of outperformance in IBT's financial year in review.
The blog can be read here:
https://www.schroders.com/en-gb/uk/individual/content/ibts-financial-year-in-review/
(https://www.schroders.com/en-gb/uk/individual/content/ibts-financial-year-in-review/)

 

To sign up for IBT updates by email, please click here
(https://www.schroders.com/en-gb/uk/individual/never-miss-an-update/) .

 

 

ENDS

 

 

Enquiries:

 

 Schroder Investment Management Limited

 Charlotte Banks (Press)                                                   020 7658 6000

 Kirsty Preston

 Kerry Higgins (Company Secretary)                                         020 7658 6000

 Kaso Legg Communications (Financial PR)

 Charles Gorman                                                            IBT@kl-communications.com (mailto:IBT@kl-communications.com)

 Henry Taylor

 Effie Aye Maung Hider

 

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRABVLFBZBLZFBZ